Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2007 Jul 18;2007(3):CD006000.
doi: 10.1002/14651858.CD006000.pub2.

Azathioprine for primary biliary cirrhosis

Y Gong  1 , E Christensen, C Gluud
Affiliations
Meta-Analysis

Azathioprine for primary biliary cirrhosis

Y Gong et al. Cochrane Database Syst Rev. .

Abstract

Background: Azathioprine is used for patients with primary biliary cirrhosis, but the therapeutic responses in randomised clinical trials have been conflicting.

Objectives: To assess the benefits and harms of azathioprine for patients with primary biliary cirrhosis.

Search strategy: Randomised clinical trials were identified by searching The Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE, EMBASE, Science Citation Index Expanded, The Chinese Biomedical Database, and LILACS, and manual searches of bibliographies to September 2005.

Selection criteria: Randomised clinical trials comparing azathioprine versus placebo, no intervention, or another drug were included irrespective of blinding, language, year of publication, and publication status.

Data collection and analysis: Our primary outcomes were mortality, and mortality or liver transplantation. Dichotomous outcomes were reported as relative risk (RR) with 95% confidence interval (CI). Continuous outcomes were reported as weighted mean difference (WMD) or standardised mean difference (SMD). We examined the intervention effects by random-effects and fixed-effect models.

Main results: We identified two randomised clinical trials with 293 patients. Only one of the trials was regarded as having low bias risk. Azathioprine did not significantly decrease mortality (RR 0.80, 95% CI 0.49 to 1.31, 2 trials). Azathioprine did not improve pruritus at one-year intervention (RR 0.71, 95% CI 0.28 to 1.84, 1 trial), cirrhosis development, or quality of life. Patients given azathioprine experienced significantly more adverse events than patients given no intervention or placebo (RR 2.44, 95% CI 1.14 to 5.20, 2 trials). The common adverse events were rash, severe diarrhoea, and bone marrow depression.

Authors' conclusions: There is no evidence to support the use of azathioprine for patients with primary biliary cirrhosis. Researchers who are interested in performing further randomised clinical trials should be aware of the risks of adverse events.

PubMed Disclaimer

Conflict of interest statement

None known. EC is the leading author of the Christensen 1985 trial. YG, EC, and CG have no affiliations or financial contracts with companies producing azathioprine.

Figures

1.1
1.1. Analysis
Comparison 1 Azathioprine versus placebo or no intervention, Outcome 1 Mortality ‐ complete patient's course analysis and best/worst case scenario.
1.2
1.2. Analysis
Comparison 1 Azathioprine versus placebo or no intervention, Outcome 2 Mortality ‐ uncertainty method.
1.3
1.3. Analysis
Comparison 1 Azathioprine versus placebo or no intervention, Outcome 3 Pruritus at one‐year intervention.
1.4
1.4. Analysis
Comparison 1 Azathioprine versus placebo or no intervention, Outcome 4 Cirrhosis development.
1.5
1.5. Analysis
Comparison 1 Azathioprine versus placebo or no intervention, Outcome 5 Quality of life.
1.6
1.6. Analysis
Comparison 1 Azathioprine versus placebo or no intervention, Outcome 6 Adverse events.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD006000

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Christensen 1985 {published data only}
    1. Christensen E, Altman DG, Neuberger J, Stavola BD, Tygstrup N, Williams R, et al. Updating prognosis in primary biliary cirrhosis using a time‐dependent Cox regression model. Gastroenterology 1993;105:1865‐76. - PubMed
    1. Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, et al. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology 1985;89(5):1084‐91. - PubMed
    1. Crowe J, Christensen E, Smith M, Cochrane M, Ranek L, Watkinson G, et al. Azathioprine in primary biliary cirrhosis: A preliminary report of an international trial. Gastroenterology 1980;78(5 I):1005‐10. - PubMed
Heathcote 1976 {published data only}
    1. Heathcote J, Ross A, Sherlock S. A prospective controlled trial of azathioprine in primary biliary cirrhosis. Gastroenterology 1976;70(5):656‐60. - PubMed
    1. Ross A, Sherlock S. A controlled trials of azathioprine in primary biliary cirrhosis (abstract). Gut 1971;12(2):770.

References to studies excluded from this review

Wolfhagen 1998 {published data only}
    1. Wolfhagen FHJ, Lim AG, Verma A, Buuren HR, Jazrwi RP, Northfield TC, et al. Soluble ICAM‐1 in primary biliary cirrhosis (PBC) during combined treatment with ursodeoxycholic acid, prednisone and azathioprine (abstract). Netherlands Journal of Medicine 1995;47:A29.
    1. Wolfhagen FHJ, Buuren HR, Berge‐Henegouwen GP, Hattum J, Ouden JW, Kerbert MJ, et al. A randomized placebo‐controlled trial with prednisone/azathioprine in addition to ursodeoxycholic acid in primary biliary cirrhosis (abstract). Journal of Hepatology 1994;21(Suppl 1):S49.
    1. Wolfhagen FHJ, Buuren HR, Berge‐Henegouwen GP, Hattum J, Ouden JW, Kerbert MJ, et al. Prednisone/azathioprine treatment in primary biliary cirrhosis (PBC). A randomized, placebo‐controlled trial (abstract). Netherlands Journal of Surgery 1995;46:A10.
    1. Wolfhagen FHJ, van Hoogstraten, Buuren HR, Berge‐Henegouwen GP, Kate FW, Hop WCJ, et al. Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1‐year randomized, placebo‐controlled study. Journal of Hepatology 1998;29:736‐42. - PubMed

Additional references

Balasubramaniam 1990
    1. Balasubramaniam K, Grambsch PM, Wiesner RH, Lindor KD, Dickson ER. Diminished survival in asymptomatic primary biliary cirrhosis: a prospective study. Gastroenterology 1990;98:1567‐71. [MEDLINE: ] - PubMed
Ballardini 1984
    1. Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF. Aberrant expression of HLA‐DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet 1984;2:1009‐13. [MEDLINE: ] - PubMed
Begg 1994
    1. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50(4):1088‐101. - PubMed
Beswick 1985
    1. Beswick DR, Klatskin G, Boyer JL. Asymptomatic primary biliary cirrhosis: a progress report on long‐term follow‐up and natural history. Gastroenterology 1985;89:267‐71. [MEDLINE: ] - PubMed
Deeks 2003
    1. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, et al. Evaluating non‐randomised intervention studies. Health Technology Assessment 2003;7(27):iii‐x, 1‐173. - PubMed
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88. [MEDLINE: ] - PubMed
Dickson 1985
    1. Dickson ER, Fleming TR, Wiesner RH, Baldus WP, Fleming CR, Ludwig J, et al. Trial of penicillamine in advanced primary biliary cirrhosis. New England Journal of Medicine 1985;312(16):1011‐5. [MEDLINE: ] - PubMed
Egger 1997
    1. Egger M, Smith GD, Schneider M, Minder C. Bias in meta‐analysis detected by a simple graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629‐34. [MEDLINE: ] - PMC - PubMed
Epstein 1982
    1. Epstein O, Chapman RWG, Lake‐Bakaar G, Foo AY, Rosalki SB, Sherlock S, et al. The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology 1982;83(6):1177‐82. [MEDLINE: ] - PubMed
Fregeau 1989
    1. Fregeau D, Water J, Danner D, Ansart T, Coppel R, Gershwin M. Antimitochondrial antibodies AMA of primary biliary cirrhosis PBC recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha ketoacid dehydrogenase complex. Faseb Journal 1989;3:A1121. [MEDLINE: ] - PubMed
Gamble 2005
    1. Gamble C, Hollis S. Uncertainty method improved on best/worst case analysis in a binary meta‐analysis. Journal of Clinical Epidemiology 2005;58:579‐88. - PubMed
Gluud 2007
    1. Gluud C, Nikolova D, Klingenberg SL, Als‐Nielsen B, D'Amico G, Davidson B, et al. Cochrane Hepato‐Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2007, Issue 2. Art. No.: LIVER.
Gong 2004
    1. Gong Y, Frederiksen SL, Gluud C. D‐penicillamine for primary biliary cirrhosis. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD004789. DOI: 10.1002/14651858.CD004789.pub2. - PMC - PubMed
Gong 2005a
    1. Gong Y, Frederiksen SL, Gluud C. Methotrexate for primary biliary cirrhosis. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD004385. DOI: 10.1002/14651858.CD004385.pub2. - PubMed
Gong 2005b
    1. Gong Y, Gluud C. Colchicine for primary biliary cirrhosis: a systematic review of randomised clinical trials. American Journal of Gastroenterology 2005;100:1876‐85. - PubMed
Gong 2005c
    1. Gong Y, Christensen E, Gluud C. Cyclosporin A for primary biliary cirrhosis. (Protocol). Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD005526. DOI: 10.1002/14651858.CD005526. - PMC - PubMed
Gong 2006
    1. Gong Y, Christensen E, Gluud C. Azathioprine for primary biliary cirrhosis. (Protocol) Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD006000. DOI: 10.1002/14651858.CD006000. - PMC - PubMed
Heathcote 1976
    1. Heathcote J, Ross A, Sherlock S. A prospective controlled trial of azathioprine in primary biliary cirrhosis. Gastroenterology 1976;70(5 Pt 1):656‐60. [MEDLINE: ] - PubMed
Higgins 2002
    1. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21:1539‐58. - PubMed
Higgins 2006
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & sons, Ltd.
Hoofnagle 1986
    1. Hoofnagle JH, Davis GL, Schafer DF, Peters M, Avigan MI, Pappas SC, et al. Randomized trial of chlorambucil for primary biliary cirrhosis. Gastroenterology 1986;91(6):1327‐34. [MEDLINE: ] - PubMed
ICH‐GCP 1997
    1. International Conference on Harmonisation of Technical Requiements for Registration of Pharmaceuticals for Human Use. Code of Federal Regulation & ICH Guidelines. Media: Parexel Barnett, 1997.
Invernizzi 1997
    1. Invernizzi P, Crosignani A, Battezzati PM, Covini G, De‐Valle G, Larghi A, et al. Comparison of the clinical features and clinical course of antimitochondrial antibody‐positive and negative primary biliary cirrhosis. Hepatology 1997;25(5):1090‐5. [MEDLINE: ] - PubMed
Ioannidis 2001
    1. Ioannidis JPA, Lau J. Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses. Proceedings of the National Academy of Sciences of the United States of America 2001;98(3):831‐6. - PMC - PubMed
James 1981
    1. James O, Macklon AF, Waston AJ. Primary biliary cirrhosis ‐ a revised clinical spectrum. Lancet 1981;1(8233):1278‐81. [MEDLINE: ] - PubMed
Kaplan 1991
    1. Kaplan MM, Knox TA. Treatment of primary biliary cirrhosis with low‐dose weekly methotrexate. Gastroenterology 1991;101:1332‐8. - PubMed
Kaplan 1996
    1. Kaplan MM. Primary biliary cirrhosis. New England Journal of Medicine 1996;335(21):1570‐80. - PubMed
Kim 2000
    1. Kim WR, Lindor KD, Locke GR 3rd, Therneau TM, Homburger HA, Batts KP, et al. Epidemiology and natural history of primary biliary cirrhosis in a U.S. community. Gatroenterology 2000;119:1631‐6. - PubMed
Kjaergard 2001
    1. Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomized trials in meta‐analyses. Annals of Internal Medicine 2001;135(11):982‐9. - PubMed
Lacerda 1995
    1. Lacerda MA, Ludwig J, Dickson ER, Jorgensen RA, Lindor KD. Antimitochondrial antibody‐negative primary biliary cirrhosis. American Journal of Gastroenterology 1995;90(2):247‐9. [MEDLINE: ] - PubMed
Lennard 1992
    1. Lennard L. The clinical pharmacology of 6‐mercaptopurine. European Journal of Clinical Pharmacology 1992;43:329‐39. - PubMed
Lindor 1995
    1. Lindor KD, Dickson ER, Jorgensen RA, Anderson ML, Wiesner RH, Gores GJ, et al. The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study. Hepatology 1995;22(4 Pt 1):1158‐62. [MEDLINE: ] - PubMed
Macaskill 2001
    1. Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta‐analysis. Statistics in Medicine 2001;20:641‐54. - PubMed
Mantel 1959
    1. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of National Cancer Institute 1959;22:719‐48. - PubMed
Mattalia 1998
    1. Mattalia A, Quaranta S, Leung PS, Bauducci M, Van‐de‐Water J, Calvo PL. Characterization of antimitochondrial antibodies in health adults. Hepatology 1998;27(3):656‐61. [MEDLINE: ] - PubMed
Metcalf 1996
    1. Metcalf J, Mitchison H, Palmer J, Jones D, Bassendine M, James O. Natural history of early primary biliary cirrhosis. Lancet 1996;348(9039):1399‐402. [MEDLINE: ] - PubMed
Minuk 1988
    1. Minuk GY, Bohme CE, Burgess E, Hershfield NB, Kelly JK, Shaffer EA, et al. Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis. Gastroenterology 1988;95:1356‐63. - PubMed
Mitchison 1992
    1. Mitchison HC, Palmer JM, Bassendine MF, Watson AJ, Record CO, James OF. A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three‐year results. Journal of Hepatology 1992;15(3):336‐44. [MEDLINE: ] - PubMed
Moher 1998
    1. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet 1998;352(9128):609‐13. [MEDLINE: ] - PubMed
Neuberger 1985
    1. Neuberger J, Christensen E, Portmann B, Caballeria J, Rodes J, Ranek L, et al. Double blind controlled trial of D‐penicillamine in patients with primary biliary cirrhosis. Gut 1985;26(2):114‐9. [MEDLINE: ] - PMC - PubMed
Nyberg 1989
    1. Nyberg A, Loof L. Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease. Scandinavian Journal of Gastroenterology 1989;24(1):57‐64. [MEDLINE: ] - PubMed
Pearson 1998
    1. Pearson DC, May GR, Fick G, Sutherland LR. Azathioprine for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews 1998, Issue 4. Art. No.: CD000067. DOI: 10.1002/14651858.CD000067. - PubMed
Pocock 2002
    1. Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Statistics in Medicine 2002;21(19):2917–30. - PubMed
Poupon 1996
    1. Poupon RE, Huet PM, Poupon R, Bonnand AM, Nhieu JT, Zafrani ES, et al. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1996;24(5):1098‐103. [MEDLINE: ] - PubMed
Prince 2000
    1. Prince M, Jones D, Metcalf J, Craig W, James O. Symptom development and prognosis of initially asymptomatic PBC. Hepatology 2000;32(4 Pt 2):171A.
Prince 2003
    1. Prince MI, James OFW. The epidemiology of primary biliary cirrhosis. Clinics in Liver Disease 2003;7:795‐819. - PubMed
Prince 2005
    1. Prince M, Christensen E, Gluud C. Glucocorticosteroids for primary biliary cirrhosis. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD003778. DOI: 10.1002/14651858.CD003778.pub2. - PMC - PubMed
RevMan 2003 [Computer program]
    1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
Royle 2003
    1. Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591‐603. - PubMed
Sandrini 2000
    1. Sandrini S, Maiorca R, Scolari F, Cancarini G, Setti G, Gaggia P, et al. A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. Transplantation 2000;69(9):1861‐7. - PubMed
Scheuer 1967
    1. Scheuer P. Primary biliary cirrhosis. Proceedings of the Royal Society of Medicine 1967;60(12):1257‐60. [MEDLINE: ] - PMC - PubMed
Schulz 1995
    1. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408‐12. [MEDLINE: ] - PubMed
Suarez‐Almazor 2000
    1. Suarez‐Almazor ME, Spooner C, Belseck E. Azathioprine for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD001461. DOI: 10.1002/14651858.CD001461. - PubMed
Turchany 1997
    1. Turchany JM, Uibo R, Kivik T, Van‐de‐Water J, Prindiville T, Coppel RL, et al. A study of antimitochondrial antibodies in a random population in Estonia. American Journal of Gastroenterology 1997;92(1):124‐6. [MEDLINE: ] - PubMed
Van den Oord 1986
    1. Oord JJ, Sciot R, Desmet VJ. Expression of MHC products by normal and abnormal bile duct epithelium. Jounal of Hepatology 1986;3(3):310‐7. [MEDLINE: ] - PubMed
Verma 1999
    1. Verma A, Jazrawi RP, Ahmed HA, Northfield TC. Prescribing habits in primary biliary cirrhosis: a national survey. European Journal of Gastroenterology and Hepatology 1999;11(8):817‐20. [MEDLINE: ] - PubMed
Vuoristo 1995
    1. Vuoristo M, Farkkila M, Karvonen AL, Leino R, Lehtola J, Makinen J, et al. A placebo‐controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid [see comments]. Gastroenterology 1995;108(5):1470‐8. [MEDLINE: ] - PubMed
Warnes 1987
    1. Warnes TW, Smith A, Lee FI, Haboubi NY, Johnson PJ, Hunt L. A controlled trial of colchicine in primary biliary cirrhosis: trial design and preliminary report. Jounal of Hepatology 1987;5(1):1‐7. [MEDLINE: ] - PubMed
Wiesner 1990
    1. Wiesner RH, Ludwig J, Lindor KD, Jorgensen RA, Baldus WP, Homburger HA, et al. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. New England Journal of Medicine 1990;322(20):1419‐24. [MEDLINE: ] - PubMed
Yamada 1986
    1. Yamada G, Hyodo I, Tobe K, Mizuno M, Nishihara T, Kobayashi T, et al. Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis. Hepatology 1986;6(3):385‐91. [MEDLINE: ] - PubMed

MeSH terms

LinkOut - more resources